Candida vulvovaginitis: Difference between revisions

(Text replacement - " dx" to " diagnosis")
Line 2: Line 2:
*Not considered an STI although it can be transmitted by sexual intercourse
*Not considered an STI although it can be transmitted by sexual intercourse
*May occur in premarnarcheal girls (rare)
*May occur in premarnarcheal girls (rare)
*Types
 
**Uncomplicated
===Types===
***Sporadic infectionn, mild-moderate sx, due to Candida albicans, immunocompetent
*Uncomplicated
**Complicated
**Sporadic infectionn
***Recurrent infectionn, severe sx, uncontrolled DM, immunosuppression, pregnant
**mild-moderate symptoms
**due to Candida albicans
**immunocompetent
*Complicated
**Recurrent infection
**severe symptoms
**uncontrolled [[DM]]
**immunosuppression
**[[pregnant]]


==Clinical Features==
==Clinical Features==

Revision as of 01:47, 3 August 2016

Background

  • Not considered an STI although it can be transmitted by sexual intercourse
  • May occur in premarnarcheal girls (rare)

Types

  • Uncomplicated
    • Sporadic infectionn
    • mild-moderate symptoms
    • due to Candida albicans
    • immunocompetent
  • Complicated
    • Recurrent infection
    • severe symptoms
    • uncontrolled DM
    • immunosuppression
    • pregnant

Clinical Features

  • Vulvar pruritus - most common and specific symptom
  • Vaginal discharge - varies from little to copious and from watery to cottage-cheese like
  • Malodorous smell is unusual (if present favors diagnosis of Bacterial vaginosis)

Differential Diagnosis

Vulvovaginitis

Evaluation

Work-up

  • Wet mount - shows hyphae and yeast buds
    • Candida does not cause WBCs on wet mount → if present, consider co-infection with other vaginitides or STI
  • If recurrent, consider checking blood glucose for occult DM

Management

  • Do not treat if asymptomatic
  • Sexual partners should not be treated unless the patient has frequent recurrences

Antifungals

Uncomplicated

There is little resistance to azole medications; treatment often dictated by patient preference.

  • Fluconazole 150mg PO once (preferred)[1]
    • A second dose at 72hrs may be given if patient is still symptomatic
  • Intravaginal therapy
    • Clotrimazole 1 % cream applied vaginally for 7 days OR
    • Clotrimazole 2% applied vaginally for 3 days
    • Miconazole 2% cream applied vaginally for 7 days OR 4% cream x 3 days
    • Butoconazole 2% applied vaginally x 3 days
    • Tioconazole 6.5% applied vaginally x 1

Complicated

Severe or immunosuppressed

Non-albicans species

  • For example, C. glabrata, C. krusei and other atypical Candida spp.
  • Boric acid vaginal suppository intravaginal qday x ≥14 days
    • Can be fatal if taken orally
  • If empirically treated and later is found to have non-albicans Candida spp., no change in therapy is needed if patient is improving (otherwise switch to boric acid.

Recurrent (≥ 4 infections in a year)

  • Treat as for uncomplicated (see above)
  • Once therapy completed, prescribe long-term treatment
    • Fluconazole 150mg PO qweek x 6 months, OR
    • Intravaginal medication, such as clotrimazole 500mg PV qweek or 200mg PV twice a week

Pregnant Patients

  • Intravaginal clotrimazole or miconazole are the only recommended treatments
  • Duration is 7 days
  • PO fluconazole associated with congenital malformations and spontaneous abortions[2]

See Also

References

  1. Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1.
  2. Molgaard-Nielsen D et al. Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. JAMA. 2016;315(1):58-67.